Loading...
OTCM
VYCO
Market cap6mUSD
Dec 04, Last price  
0.20USD
1D
-1.00%
1Q
53.49%
Jan 2017
-41.75%
IPO
890.00%
Name

Vycor Medical Inc

Chart & Performance

D1W1MN
OTCM:VYCO chart
P/E
P/S
4.16
EPS
Div Yield, %
Shrs. gr., 5y
6.54%
Rev. gr., 5y
1.41%
Revenues
2m
+8.81%
2,565129,947199,046316,450971,3671,205,2631,089,3741,250,2921,138,6341,452,7141,384,9711,509,3301,481,7511,142,0451,392,9871,222,9891,460,6041,589,324
Net income
-107k
L+53.82%
-593,996-2,381,295-1,141,383-1,961,662-4,778,541-2,926,210-2,472,773-4,049,713-2,082,643-1,652,280-1,477,045-1,379,356-864,885-900,296-523,473-405,881-69,691-107,200
CFO
60k
+104.25%
-429,633-1,171,622-543,786-1,450,270-3,195,334-1,370,930-730,143-2,700,769-1,167,500-496,918-527,438-260,3227,221-248,79121,369-217,01629,43060,110

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Vycor Medical, Inc. designs, develops, and markets neurological medical devices and therapies in the United States and Europe. It operates in two segments, Vycor Medical and NovaVision. The Vycor Medical segment provides devices for neurosurgery comprising ViewSite Brain Access System, a retraction and access system for brain and spine surgeries. The NovaVision segment offers non-invasive computer-based rehabilitation targeted at people who have impaired vision as a result of stroke or other brain injury. Vycor Medical, Inc. has a license and transition agreement with HelferApp GmbH, which grants HelferApp the license to provide NovaVision's products and therapies to patients and professionals in Austria and Switzerland. The company primarily serves hospitals and medical professionals. Vycor Medical, Inc. was incorporated in 2005 and is headquartered in Boca Raton, Florida. Vycor Medical, Inc. is a subsidiary of Fountainhead Capital Management Limited.
IPO date
Mar 31, 2009
Employees
6
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT